P38 Mitogen-activated Protein Kinase Promotes Cell Survival in Response to DNA Damage but is Not Required for the G(2) DNA Damage Checkpoint in Human Cancer Cells

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2010 Jun 3

PMID 20516219

Citations 28

Authors

Mark S Phong

Robert D Van Horn

Shuyu Li

Gregory Tucker-Kellogg

Uttam Surana

Xiang S Ye

Affiliations

Soon will be listed here.

Abstract

p38 mitogen-activated protein kinase (MAPK) is rapidly activated by stresses and is believed to play an important role in the stress response. While Chk1 is known to mediate G(2) DNA damage checkpoint control, p38 was also reported to have an essential function in this checkpoint control. Here, we have investigated further the roles of p38 and Chk1 in the G(2) DNA damage checkpoint in cancer cells. We find that although p38 activation is strongly induced by DNA damage, its activity is not required for the G(2) DNA damage checkpoint. In contrast, Chk1 kinase is responsible for the execution of G(2) DNA damage checkpoint control in p53-deficient cells. The inhibition of p38 activity has no effect on Chk1 activation and gamma-H2AX expression. Global gene expression profiling of cancer cells in response to tumor necrosis factor alpha (TNF-alpha) revealed that p38 plays a strong prosurvival role through the coordinated downregulation of proapoptotic genes and upregulation of prosurvival genes. We show that the inhibition of p38 activity during G(2) DNA damage checkpoint arrest triggers apoptosis in a p53-independent manner with a concurrent decrease in the level of Bcl2 family proteins. Our results suggest that although p38 MAPK is not required for the G(2) DNA damage checkpoint function, it plays an important prosurvival role during the G(2) DNA damage checkpoint response through the upregulation of the Bcl2 family proteins.

Citing Articles

JNK Inhibition Overcomes Resistance of Metastatic Tetraploid Cancer Cells to Irradiation-Induced Apoptosis.

Jemaa M, Setti Boubaker N, Kerkeni N, M Huber S Int J Mol Sci. 2025; 26(3).

PMID: 39940976 PMC: 11818936. DOI: 10.3390/ijms26031209.

The Interplay between the DNA Damage Response (DDR) Network and the Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Multiple Myeloma.

Malamos P, Papanikolaou C, Gavriatopoulou M, Dimopoulos M, Terpos E, Souliotis V Int J Mol Sci. 2024; 25(13).

PMID: 39000097 PMC: 11241508. DOI: 10.3390/ijms25136991.

Multiomic profiling of breast cancer cells uncovers stress MAPK-associated sensitivity to AKT degradation.

Erickson E, You I, Perry G, Dugourd A, Donovan K, Crafter C Sci Signal. 2024; 17(825):eadf2670.

PMID: 38412255 PMC: 10949348. DOI: 10.1126/scisignal.adf2670.

The Bidirectional Link Between RNA Cleavage and Polyadenylation and Genome Stability: Recent Insights From a Systematic Screen.

Spada S, Luke B, Danckwardt S Front Genet. 2022; 13:854907.

PMID: 35571036 PMC: 9095915. DOI: 10.3389/fgene.2022.854907.

Pharmacological Targeting of STING-Dependent IL-6 Production in Cancer Cells.

Al-Asmari S, Rajapakse A, Ullah T, Pepin G, Croft L, Gantier M Front Cell Dev Biol. 2022; 9:709618.

PMID: 35087822 PMC: 8787270. DOI: 10.3389/fcell.2021.709618.

References

Fabian M, Biggs 3rd W, Treiber D, Atteridge C, Azimioara M, Benedetti M . A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol. 2005; 23(3):329-36. DOI: 10.1038/nbt1068. View

Li S, Zhang H, Hu C, Lawrence F, Gallagher K, Surapaneni A . Assessment of diet-induced obese rats as an obesity model by comparative functional genomics. Obesity (Silver Spring). 2008; 16(4):811-8. DOI: 10.1038/oby.2007.116. View

Enders G . Expanded roles for Chk1 in genome maintenance. J Biol Chem. 2008; 283(26):17749-52. PMC: 2440615. DOI: 10.1074/jbc.R800021200. View

Levesque A, Fanous A, Poh A, Eastman A . Defective p53 signaling in p53 wild-type tumors attenuates p21waf1 induction and cyclin B repression rendering them sensitive to Chk1 inhibitors that abrogate DNA damage-induced S and G2 arrest. Mol Cancer Ther. 2008; 7(2):252-62. DOI: 10.1158/1535-7163.MCT-07-2066. View

Wegiel B, Bjartell A, Culig Z, Persson J . Interleukin-6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival. Int J Cancer. 2007; 122(7):1521-9. DOI: 10.1002/ijc.23261. View

Manke I, Nguyen A, Lim D, Stewart M, Elia A, Yaffe M . MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol Cell. 2005; 17(1):37-48. DOI: 10.1016/j.molcel.2004.11.021. View

Bulavin D, Higashimoto Y, Popoff I, Gaarde W, Basrur V, Potapova O . Initiation of a G2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature. 2001; 411(6833):102-7. DOI: 10.1038/35075107. View

Fan L, Yang X, Du J, Marshall M, Blanchard K, Ye X . A novel role of p38 alpha MAPK in mitotic progression independent of its kinase activity. Cell Cycle. 2005; 4(11):1616-24. DOI: 10.4161/cc.4.11.2125. View

Ono K, Han J . The p38 signal transduction pathway: activation and function. Cell Signal. 2000; 12(1):1-13. DOI: 10.1016/s0898-6568(99)00071-6. View

10.

Koniaras K, Cuddihy A, Christopoulos H, Hogg A, Oconnell M . Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells. Oncogene. 2001; 20(51):7453-63. DOI: 10.1038/sj.onc.1204942. View

11.

Bowen W, Wylie P . Application of laser-scanning fluorescence microplate cytometry in high content screening. Assay Drug Dev Technol. 2006; 4(2):209-21. DOI: 10.1089/adt.2006.4.209. View

12.

Bulavin D, Saito S, Hollander M, Sakaguchi K, Anderson C, Appella E . Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J. 1999; 18(23):6845-54. PMC: 1171747. DOI: 10.1093/emboj/18.23.6845. View

13.

Pietersma A, Tilly B, Gaestel M, de Jong N, Lee J, Koster J . p38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. Biochem Biophys Res Commun. 1997; 230(1):44-8. DOI: 10.1006/bbrc.1996.5886. View

14.

Didier C, Cavelier C, Quaranta M, Galcera M, Demur C, Laurent G . G2/M checkpoint stringency is a key parameter in the sensitivity of AML cells to genotoxic stress. Oncogene. 2008; 27(27):3811-20. DOI: 10.1038/sj.onc.1211041. View

15.

Han J, Lee J, Bibbs L, Ulevitch R . A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 1994; 265(5173):808-11. DOI: 10.1126/science.7914033. View

16.

Guan Z, Buckman S, Pentland A, Templeton D, Morrison A . Induction of cyclooxygenase-2 by the activated MEKK1 --> SEK1/MKK4 --> p38 mitogen-activated protein kinase pathway. J Biol Chem. 1998; 273(21):12901-8. DOI: 10.1074/jbc.273.21.12901. View

17.

Pedraza-Alva G, Koulnis M, Charland C, Thornton T, Clements J, Schlissel M . Activation of p38 MAP kinase by DNA double-strand breaks in V(D)J recombination induces a G2/M cell cycle checkpoint. EMBO J. 2006; 25(4):763-73. PMC: 1383553. DOI: 10.1038/sj.emboj.7600972. View

18.

Yang H, Burke T, Dempsey J, Diaz B, Collins E, Toth J . Mitotic requirement for aurora A kinase is bypassed in the absence of aurora B kinase. FEBS Lett. 2005; 579(16):3385-91. DOI: 10.1016/j.febslet.2005.04.080. View

19.

Schieven G . The p38alpha kinase plays a central role in inflammation. Curr Top Med Chem. 2009; 9(11):1038-48. DOI: 10.2174/156802609789630974. View

20.

Gatti G, Maresca G, Natoli M, Florenzano F, Nicolin A, Felsani A . MYC prevents apoptosis and enhances endoreduplication induced by paclitaxel. PLoS One. 2009; 4(5):e5442. PMC: 2673584. DOI: 10.1371/journal.pone.0005442. View